Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's disease

被引:15
|
作者
Willumsen, Nanet [1 ,2 ]
Poole, Teresa [3 ,4 ]
Nicholas, Jennifer M. [3 ,4 ]
Fox, Nick C. [4 ,5 ]
Ryan, Natalie S. [4 ,5 ]
Lashley, Tammaryn [1 ,2 ]
机构
[1] UCL Queen Sq Inst Neurol, Queen Sq Brain Bank Neurol Disorders, Dept Clin & Movement Neurosci, London, England
[2] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London WC1N 1PJ, England
[3] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[4] UCL Queen Sq Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London, England
[5] UCL, UK Dementia Res Inst, London, England
基金
英国医学研究理事会;
关键词
Alzheimer's disease; amyloid; familial Alzheimer's disease; COTTON WOOL PLAQUES; CEREBRAL AMYLOID ANGIOPATHY; SPASTIC PARAPARESIS; NEUROPATHOLOGIC ASSESSMENT; LAMINAR DISTRIBUTIONS; INTELLECTUAL STATUS; VARIABLE PHENOTYPE; SENILE DEMENTIA; ONSET; MUTATION;
D O I
10.1111/bpa.13009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Familial Alzheimer's disease (FAD) is caused by autosomal dominant mutations in the PSEN1, PSEN2 or APP genes, giving rise to considerable clinical and pathological heterogeneity in FAD. Here we investigate variability in clinical data and the type and distribution of A beta pathologies throughout the cortical layers of different FAD mutation cases. Brain tissue from 20 FAD cases [PSEN1 pre-codon 200 (n = 10), PSEN1 post-codon 200 (n = 6), APP (n = 4)] were investigated. Frontal cortex sections were stained immunohistochemically for A beta, and Nissl to define the cortical layers. The frequency of different amyloid-beta plaque types was graded for each cortical layer and the severity of cerebral amyloid angiopathy (CAA) was determined in cortical and leptomeningeal blood vessels. Comparisons were made between FAD mutations and APOE4 status, with associations between pathology, clinical and genetic data investigated. In this cohort, possession of an APOE4 allele was associated with increased disease duration but not with age at onset, after adjusting for mutation sub-group and sex. We found A beta pathology to be heterogeneous between cases although A beta load was highest in cortical layer 3 for all mutation groups and a higher A beta load was associated with APOE4. The PSEN1 post-codon 200 group had a higher A beta load in lower cortical layers, with a small number of this group having increased cotton wool plaque pathology in lower layers. Cotton wool plaque frequency was positively associated with the severity of CAA in the whole cohort and in the PSEN1 post-codon 200 group. Carriers of the same PSEN1 mutation can have differing patterns of A beta deposition, potentially because of differences in risk factors. Our results highlight possible influences of APOE4 genotype, and PSEN1 mutation type on A beta deposition, which may have effects on the clinical heterogeneity of FAD.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
    Spillantini, MG
    Crowther, RA
    Goedert, M
    ACTA NEUROPATHOLOGICA, 1996, 92 (01) : 42 - 48
  • [22] Familial Alzheimer's Disease and Recessive Modifiers
    Velez, Jorge I.
    Lopera, Francisco
    Silva, Claudia T.
    Villegas, Andres
    Espinosa, Lady G.
    Vidal, Oscar M.
    Mastronardi, Claudio A.
    Arcos-Burgos, Mauricio
    MOLECULAR NEUROBIOLOGY, 2020, 57 (02) : 1035 - 1043
  • [23] Variations in the neuropathology of familial Alzheimer's disease
    Shepherd, Claire
    McCann, Heather
    Halliday, Glenda Margaret
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 37 - 52
  • [24] Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease
    Arezoumandan, Sanaz
    Xie, Sharon X.
    Cousins, Katheryn A. Q.
    Mechanic-Hamilton, Dawn J.
    Peterson, Claire S.
    Huang, Camille Y.
    Ohm, Daniel T.
    Ittyerah, Ranjit
    McMillan, Corey T.
    Wolk, David A.
    Yushkevich, Paul
    Trojanowski, John Q.
    Lee, Edward B.
    Grossman, Murray
    Phillips, Jeffrey S.
    Irwin, David J.
    ACTA NEUROPATHOLOGICA, 2022, 144 (06) : 1103 - 1116
  • [25] Biomarkers in Sporadic and Familial Alzheimer's Disease
    Lista, Simone
    O'Bryant, Sid E.
    Blennow, Kaj
    Dubois, Bruno
    Hugon, Jacques
    Zetterberg, Henrik
    Hampel, Harald
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (02) : 291 - 317
  • [26] Pathology of clinical and preclinical Alzheimer’s disease
    Dietmar Rudolf Thal
    Christine von Arnim
    W. Sue T. Griffin
    Haruyasu Yamaguchi
    Robert E. Mrak
    Johannes Attems
    Ajeet Rijal Upadhaya
    European Archives of Psychiatry and Clinical Neuroscience, 2013, 263 : 137 - 145
  • [27] Lewy body pathology in Alzheimer's disease
    Kotzbauer, PT
    Trojanowski, JQ
    Lee, VMY
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2001, 17 (02) : 225 - 232
  • [28] Lewy body pathology in Alzheimer’s disease
    Paul T. Kotzbauer
    John Q. Trojanowski
    Virginia M.-Y. Lee
    Journal of Molecular Neuroscience, 2001, 17 : 225 - 232
  • [29] Role of liraglutide in Alzheimer's disease pathology
    Vargas-Soria, Maria
    Carranza-Naval, Maria Jose
    Del Marco, Angel
    Garcia-Alloza, Monica
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [30] Role of liraglutide in Alzheimer’s disease pathology
    Maria Vargas-Soria
    Maria Jose Carranza-Naval
    Angel del Marco
    Monica Garcia-Alloza
    Alzheimer's Research & Therapy, 13